PCM
PODD icon

Prelude Capital Management’s Insulet PODD Stock Holding History

Prelude Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,000
Closed -$237K – 2111
2014
Q1 		$237K Buy
+5,000
New +$221K 0.03% 669
2013
Q3 		– Sell
-4,000
Closed -$126K – 1814
2013
Q2 		$126K Buy
+4,000
New +$113K 0.03% 575

Other funds holding PODD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Prelude Capital Management's PODD Position: Q4 2025 in Review

Prelude Capital Management sold out of Insulet (PODD) in Q4 2025, closing a stake of 1,241 shares — an estimated $383K sold.

Prelude Capital Management first reported a position in PODD in Q3 2016 and held it in 26 quarters. The position peaked at $2.54M in Q2 2021. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • Prelude Capital Management reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 1,241 Insulet shares in Q4 2025, an estimated $383K.
  • Prelude Capital Management first reported a position in Insulet in Q3 2016 and held it in 26 quarters.
  • Prelude Capital Management's Insulet position peaked at $2.54M in Q2 2021.
  • 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.